The differential prognostic impact of spread through air spaces in early-stage lung adenocarcinoma after lobectomy according to the pT descriptor

J Thorac Cardiovasc Surg. 2022 Jan;163(1):277-284.e1. doi: 10.1016/j.jtcvs.2020.09.098. Epub 2020 Oct 7.

Abstract

Objectives: We evaluated the differential prognostic impact of spread through air spaces (STAS) in early-stage lung adenocarcinoma after lobectomy according to the pT descriptor.

Methods: The study population included 506 patients who underwent lobectomy with mediastinal lymph node dissection for pT1b, pT1c, and pT2a adenocarcinoma between 2011 and 2016. We divided the study population into 2 groups according to STAS status, ie, STAS (+) versus STAS (-), and stratified them according to the pT descriptor. A Cox proportional hazard model and inverse probability of treatment weight-adjusted Kaplan-Meier curves were used to evaluate the prognostic impact of STAS on recurrence-free survival (RFS) and its independency in each stratum.

Results: Multivariable Cox proportional hazard regression analysis demonstrated that in pT1b and pT1c strata, STAS (+) patients had a 7.02-fold and 2.89-fold greater risk of recurrence than STAS (-) patients, respectively. However, in the pT2a stratum, STAS did not affect RFS. And the RFS of the STAS (+) pT1b/c strata was similar to that of the pT2a stratum. In the pT1b/c strata, inverse probability of treatment weighting-adjusted Kaplan-Meier curves also showed that RFS was significantly worse when STAS was present. Furthermore, the risks for locoregional and distant recurrence were both greater when STAS was present.

Conclusions: The presence of STAS increased the risk of recurrence independently from other poor prognostic factors in patients with pT1b/cN0M0 adenocarcinoma who underwent lobectomy, but not in pT2a patients. The presence of STAS in pT1b/cN0M0 adenocarcinoma was associated with a similar risk of recurrence to that of pT2aN0M0 adenocarcinoma.

Keywords: early stage; lung adenocarcinoma; spread through air space (STAS).

MeSH terms

  • Adenocarcinoma of Lung* / pathology
  • Adenocarcinoma of Lung* / surgery
  • Chemotherapy, Adjuvant / methods
  • Chemotherapy, Adjuvant / statistics & numerical data
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / surgery
  • Lung* / pathology
  • Lung* / surgery
  • Lymph Node Excision / methods
  • Lymph Nodes / surgery*
  • Male
  • Mediastinum
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Invasiveness* / pathology
  • Neoplasm Invasiveness* / prevention & control
  • Neoplasm Recurrence, Local* / etiology
  • Neoplasm Recurrence, Local* / pathology
  • Neoplasm Recurrence, Local* / prevention & control
  • Neoplasm Staging
  • Pneumonectomy* / adverse effects
  • Pneumonectomy* / methods
  • Prognosis
  • Progression-Free Survival